SILEANE specialists of robotics and vision.
Tilkal is a Paris-based company founded in 2017 that specializes in developing a software platform for traceability across supply chains. Its end-to-end, real-time traceability solution integrates permissioned blockchain networks with big data to facilitate secure and verifiable data sharing among various supply chain stakeholders. The platform allows businesses to record traceability data of physical products in a ledger, enhancing compliance, transparency, and consumer trust. Tilkal's technology is actively utilized by major corporations such as Groupe Casino and Danone, providing them with the tools to analyze traceability data, manage sourcing risks, and demonstrate environmental, social, and governance (ESG) commitments. By focusing on resilience, sustainability, and ethical practices, Tilkal aims to improve the overall integrity of supply chains across diverse industries.
Releaf Paper is a producer of sustainable paper products from fallen leaves. They work on the task of finding a solution to achieve sustainability in the production of paper using new raw materials - fallen leaves, instead of wood.
Ganymed Robotics SAS, a medical device company, focuses on the development of robotics technologies for orthopedic surgeons. It develops a therapeutic device to enhance surgical precision in knee replacement surgery. The company was incorporated in 2018 and is based in Paris, France.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
Orixha has developped an innovative device for cooling patients within few minutes and thus improve their prognosis by using a dedicated liquid ventilator able to perform safe and efficient total liquid ventilation. This method consists in filling the lungs with liquid perfluorocarbons and due to the high gases solubility and the large pulmonary sufaces can use the lungs as heat exchanger.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
Qarnot is a company based in Montrouge, France, founded in 2010, that specializes in providing economical and ecological high-performance computing (HPC) solutions through its innovative Q.rad computing heater. This unique product combines the functionality of an electrical heater with high-performance computing capabilities, utilizing embedded microprocessors to generate heat during computation. Qarnot's computing heaters have undergone three generations of development and are marketed to construction companies for use in new buildings. By integrating computing and heating, Qarnot offers an affordable alternative to traditional data centers, significantly reducing costs associated with infrastructure, maintenance, and cooling. Users can conveniently manage the temperature of these heaters through an embedded thermostat or a smartphone application, enhancing the overall user experience.
Quanturi Oy, founded in 2016 and based in Espoo, Finland, specializes in the development and provision of continuous monitoring solutions for fermentable products, catering to the agricultural, forestry, and waste sectors. The company offers a range of wireless monitoring systems, including those for compost temperature, grain management, and hay monitoring, ensuring the safety and quality of stored materials. Its platform provides real-time alerts for potential hazards, enhancing traceability and reducing handling costs. By enabling farmers and industry professionals to monitor their products effectively, Quanturi aims to prevent business disruptions and mitigate risks associated with spoilage or accidents. The company has expanded its presence across various countries, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium, and sells its products online to reach a broader market.
Aviwell is focused on creating healthy, natural, and sustainable solutions aimed at enhancing animal health and growth, thereby contributing to global nourishment. The company operates a microbiota-based discovery platform that leverages artificial intelligence and machine learning to bridge digital and life sciences. By developing innovative food products, Aviwell seeks to provide valuable insights into animal health, growth, and performance, ultimately supporting the agri-food industry in its efforts to sustainably meet the needs of a growing population.
Qubit Pharmaceuticals, incorporated in 2020 and based in Paris, France, develops innovative technology aimed at enhancing pharmaceutical drug discovery. The company offers a drug discovery simulation platform that reduces the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, Qubit's platform conducts virtual screening and visualization to identify promising drug candidates. This approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.
Novolyze, SAS is a French company that specializes in food safety solutions for the global food processing industry. Established in 2012 and headquartered in Daix, with an additional office in Cambridge, Massachusetts, Novolyze provides a comprehensive range of equipment, including steam pasteurizers, sterilizers, dryers, roasters, extruders, and ovens. The company is also known for its innovative surrogate microorganisms technology, which allows food manufacturers to test the effectiveness of microbial kill steps under real-life conditions. In addition to its equipment offerings, Novolyze provides services in pasteurization, regulatory compliance, and process validation, as well as food microbiology research to a diverse clientele that includes large corporations, small and medium enterprises, public and private research laboratories, and food processing associations. With a strong emphasis on enhancing food safety and quality, Novolyze employs a team of experts, including food microbiologists and process engineers, and operates state-of-the-art facilities in a pharmaceutical-grade environment for research and development.
PrediSurge is a software company that offers design and support solutions for physicians and medical device companies.
Perha Pharmaceuticals is a biotechnology company dedicated to the research and development of innovative therapies aimed at addressing hearing loss and cognitive disorders. The company focuses on preventing cisplatin-induced hearing loss and developing treatments for cognitive conditions related to Down syndrome and Alzheimer's disease. Perha Pharmaceuticals leverages natural marine substances in its research, with chemists and biologists optimizing molecules derived from marine organisms to create effective kinase inhibitors. This approach underscores the company's commitment to advancing medical treatments and improving patient care in areas of significant unmet need.
Dracula Technologies SAS specializes in the design and manufacture of organic photovoltaic cells aimed at providing energy autonomy for connected devices. Founded in 2011 and based in Valence, France, the company develops products that enable small electronic devices, such as phones, GPS units, and lamps, to self-recharge using solar energy. Their flagship product, Light As Your Energetic Response (LAYER), is designed to capture various forms of light, both indoors and outdoors, and convert it into usable energy through advanced digital printing techniques. The team consists of approximately 20 members, including a scientific committee and an administrative committee, all dedicated to fostering innovation and collaboration within the company. Dracula Technologies operates as a subsidiary of Ardeje.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Connecting Food is a foodtech company based in Paris, France, that specializes in a blockchain-based platform for real-time tracking and auditing of food products. Established in 2016, the company offers LiveAudit, an application that allows digital auditing of product quality throughout the entire production process. This platform enables consumers, particularly those purchasing eggs, to access detailed information about the hen's breed, the farm of origin, and the packing location. By leveraging blockchain technology, Connecting Food provides a transparent supply chain solution that fosters trust among farmers, manufacturers, retailers, and consumers, thereby enhancing brand equity and ensuring the integrity of agricultural and finished products.
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies. The company uses proprietary gene editing and plant biotechnology to drastically reduce the cost of making growth factors. The growth factors are molecules used in the clean meat and cell therapy industries.
Scipio Bioscience is a biotechnology company based in Paris, France, founded in 2017. The company specializes in manufacturing benchtop kits that serve as a sample preparation solution for single-cell studies. These kits are designed for use in sequencing applications within both clinical and basic research, focusing particularly on transcriptomics. By enabling single-cell barcoding in a test tube format, Scipio Bioscience's products facilitate advanced research in single-cell analysis, supporting laboratories in their scientific endeavors.
Spartha Medical is a medical technology company focused on developing eco-friendly, invisible coatings designed for medical devices and consumer products to mitigate microbial and inflammatory risks. Utilizing natural biopolymers, the company’s innovative coatings possess antibacterial, antiviral, and anti-inflammatory properties, providing an effective solution for infection control. The technology relies on a patented method of supramolecular assembly, enabling precise control over the properties of the coatings based on specific applications. This approach allows for the creation of multifunctional and easy-to-apply surface treatments that help healthcare institutions maintain disease-free environments on medical devices.
Perha Pharmaceuticals is a biotechnology company dedicated to the research and development of innovative therapies aimed at addressing hearing loss and cognitive disorders. The company focuses on preventing cisplatin-induced hearing loss and developing treatments for cognitive conditions related to Down syndrome and Alzheimer's disease. Perha Pharmaceuticals leverages natural marine substances in its research, with chemists and biologists optimizing molecules derived from marine organisms to create effective kinase inhibitors. This approach underscores the company's commitment to advancing medical treatments and improving patient care in areas of significant unmet need.
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles. They develop a bioproduction platform to produce extracellular vesicles at a commercial scale in a GMP compliant way for pharmaceutical companies with applications in regenerative medicine and drug delivery. Extracellular vesicles that encompass exosomes, microvesicles, and apoptotic bodies are the tools used by cells to communicate with each other. EVerZom was founded in 2019 and is headquartered in Paris, Ile-de-France, France.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
ThrustMe is a startup emerging from the Laboratoire de Physique des Plasmas at the Ecole Polytechnique and the CNRS, founded by Ane Aanesland and Dmytro Rafalskyi. The company specializes in the development, production, and commercialization of next-generation space propulsion systems utilizing its patented technology. With a focus on simplifying and enhancing the efficiency of electric propulsion, ThrustMe provides tailored solutions for both next-generation satellites and ground testing of space hardware. This approach supports space teams and aerospace businesses in achieving economic and environmental sustainability through advanced propulsion options, addressing the evolving needs of the satellite industry and the growing demand for data and global intelligence.
SiPearl is a semiconductor company that commercializes the work of the European Processor Initiative (EPI) and bring a low-power microprocessor to market for exascale supercomputing. The company aims to design, market, and distribute its first range of processors with a commercial launch in 2022 based on a roadmap closely aligned with the European Union’s goals. It has already committed to producing its chips using N6 or better processes from TSMC. It was founded in 2019 and headquartered in Maisons-Laffitte, Île-de-France.
Epigene Labs SAS, founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, develops a biotechnology platform that harnesses advanced artificial intelligence to transform genomic data into actionable insights for precision oncology. The platform addresses the challenges of aggregating, analyzing, and visualizing extensive genomic datasets, which are crucial for advancing precision oncology. By integrating proprietary data from partners with publicly available information, Epigene Labs provides medical researchers with user-friendly analytics and insights that facilitate drug development and research in cancer treatment. The company focuses on forming value-based partnerships with leading cancer centers and prominent biotech firms to enhance the efficacy of oncology solutions.
Powder is a startup that helps to share video clips of favorite games, follow people with the same interests and interact with them.
Producer of food ingredients intended to provide upcycled ingredients for nutrition. The company's fermentation platform transforms wasted fruit and vegetable by-products into low-carb flour with improved nutritional value and functionality, enabling clients to get flour that is high in protein and dietary fiber, while being low in starch, sugars, and fats.
Xenothera SAS is a biotechnology company based in Nantes, France, focused on advancing immunological treatments through its innovative platform. Established in 2014, the company specializes in developing therapeutic solutions targeting various medical areas, including immunomodulation and infectious diseases. Its approach leverages proprietary Glyco-Humanized Antibodies and integrates expertise in animal genetics and immunology to create a new generation of hyperimmune polyclonal sera. By renovating passive immunotherapy, Xenothera aims to address unmet medical needs and facilitate the rapid development of new immunological therapies. The company's comprehensive platform allows for streamlined processes, from selecting immunogens to purifying immunoglobulins, ultimately aiming for expedited market authorization.
Xenothera SAS is a biotechnology company based in Nantes, France, focused on advancing immunological treatments through its innovative platform. Established in 2014, the company specializes in developing therapeutic solutions targeting various medical areas, including immunomodulation and infectious diseases. Its approach leverages proprietary Glyco-Humanized Antibodies and integrates expertise in animal genetics and immunology to create a new generation of hyperimmune polyclonal sera. By renovating passive immunotherapy, Xenothera aims to address unmet medical needs and facilitate the rapid development of new immunological therapies. The company's comprehensive platform allows for streamlined processes, from selecting immunogens to purifying immunoglobulins, ultimately aiming for expedited market authorization.
Lactips is a French company founded in 2014 and headquartered in Lyon. It specializes in manufacturing biodegradable and water-soluble thermoplastic pellets derived from milk protein. The company employs a proprietary industrial process to produce these pellets quickly and in high volumes, making them suitable for various applications, including thermoforming and films. Lactips aims to offer its industrial clients innovative and sustainable alternatives to traditional oil-based plastics, aligning with its commitment to environmental sustainability and efficiency. By providing these disruptive solutions, Lactips supports its clients in accessing new markets while promoting a cleaner and more sustainable approach to plastic usage.
Oledcomm S.A.S. is a company based in Paris, France, that specializes in the design and manufacture of Li-Fi (light fidelity) network interface devices, which facilitate high-speed wireless data communication. Established in 2005, Oledcomm offers a range of products including Li-Fi routers, hubs, switches, and accessories tailored for various applications such as indoor location services, Internet of Things connectivity, and communication in sectors like telecom, datacom, personal electronics, and industrial markets. Their product lineup includes the GEOLiFi LED router and LiFiNET routers, along with development kits and the LiFiCLOUD platform. Oledcomm's solutions cater to diverse environments including museums, retail spaces, hospitals, offices, and smart cities, emphasizing environmentally friendly wireless communication.
Oledcomm S.A.S. is a company based in Paris, France, that specializes in the design and manufacture of Li-Fi (light fidelity) network interface devices, which facilitate high-speed wireless data communication. Established in 2005, Oledcomm offers a range of products including Li-Fi routers, hubs, switches, and accessories tailored for various applications such as indoor location services, Internet of Things connectivity, and communication in sectors like telecom, datacom, personal electronics, and industrial markets. Their product lineup includes the GEOLiFi LED router and LiFiNET routers, along with development kits and the LiFiCLOUD platform. Oledcomm's solutions cater to diverse environments including museums, retail spaces, hospitals, offices, and smart cities, emphasizing environmentally friendly wireless communication.
Qubit Pharmaceuticals, incorporated in 2020 and based in Paris, France, develops innovative technology aimed at enhancing pharmaceutical drug discovery. The company offers a drug discovery simulation platform that reduces the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, Qubit's platform conducts virtual screening and visualization to identify promising drug candidates. This approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.
UPMEM is implementing the first scalable, programmable and efficient Processing-In-Memory (PIM) solution for the datacenter.
In server architectures, Big Data processing performance is limited by data movements. UPMEM solution accelerates 10+ times data-intensive applications with an innovative solution based on a large number of programmable co-processors located next to the data.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Nestwave SAS, established in 2014 and based in Paris, France, specializes in developing geolocation systems tailored for the Internet of Things (IoT) market. The company provides innovative geolocation solutions that leverage patented hybrid-signal technology to enhance localization accuracy, particularly in challenging indoor and dense urban settings. Nestwave's platform integrates a digital signal processing (DSP) software solution, enabling IoT modem and DSP vendors to incorporate accurate geolocation capabilities into their products. This approach not only improves reliability and accuracy but also minimizes power consumption and reduces the overall footprint of the solution compared to traditional methods.
CorWave SA is a medical device company based in Clichy, France, specializing in the development and manufacture of heart-assist pumps. Founded in 2011, CorWave focuses on innovative technologies to improve patient outcomes in advanced heart failure. Its flagship product, the CorWave Left Ventricular Assist Device (LVAD), employs a unique undulating disc wave pumping mechanism that mimics the natural pulsatile flow of the heart, significantly reducing trauma to the blood and minimizing complications such as clotting and bleeding. This technology contrasts with traditional continuous flow pumps, which lack significant pulsation. Additionally, the company offers Nemo, a minimally invasive cardiac pump designed for patients who are not candidates for LVADs, providing chronic, partial support. CorWave's devices are characterized by low power consumption and compact design, which may enable total implantability with wireless energy transfer systems.
SILEANE specialists of robotics and vision.
Separative is a startup bringing a break in the purification of molecules in organic chemistry and peptides.
CarThera SAS specializes in the design and development of therapeutic ultrasound-based medical devices aimed at treating brain disorders. Founded in 2010 and headquartered in Paris, France, the company has developed innovative devices such as SonoProbe, which addresses conditions like brain tumors, epilepsy, metastases, and meningioma. Another key product is SonoCloud, an intracranial ultrasound implant that temporarily opens the blood-brain barrier, enhancing the delivery and concentration of therapeutic molecules for the treatment of primary brain tumors. Through these advancements, CarThera is focused on improving treatment outcomes for patients with serious neurological conditions.
CarThera SAS specializes in the design and development of therapeutic ultrasound-based medical devices aimed at treating brain disorders. Founded in 2010 and headquartered in Paris, France, the company has developed innovative devices such as SonoProbe, which addresses conditions like brain tumors, epilepsy, metastases, and meningioma. Another key product is SonoCloud, an intracranial ultrasound implant that temporarily opens the blood-brain barrier, enhancing the delivery and concentration of therapeutic molecules for the treatment of primary brain tumors. Through these advancements, CarThera is focused on improving treatment outcomes for patients with serious neurological conditions.
Osivax SAS is a clinical-stage biotechnology company based in Paris, France, founded in 2017. The company specializes in the development of innovative vaccines and immunotherapies aimed at addressing infectious diseases and enhancing immune responses. Its proprietary technology includes oligoDOM v1.0 and oligoDOM v2.0, which are designed to improve both B and T-cell immune responses by facilitating the uptake of antigens into dendritic cells. This results in more effective immune responses, including significant activation of CD8 T cells. Osivax's approach allows for the development of a universal vaccine targeting various infectious diseases, including influenza, malaria, and emerging coronavirus strains, while also showing potential applications in cancer treatment.
Osivax SAS is a clinical-stage biotechnology company based in Paris, France, founded in 2017. The company specializes in the development of innovative vaccines and immunotherapies aimed at addressing infectious diseases and enhancing immune responses. Its proprietary technology includes oligoDOM v1.0 and oligoDOM v2.0, which are designed to improve both B and T-cell immune responses by facilitating the uptake of antigens into dendritic cells. This results in more effective immune responses, including significant activation of CD8 T cells. Osivax's approach allows for the development of a universal vaccine targeting various infectious diseases, including influenza, malaria, and emerging coronavirus strains, while also showing potential applications in cancer treatment.
Osivax SAS is a clinical-stage biotechnology company based in Paris, France, founded in 2017. The company specializes in the development of innovative vaccines and immunotherapies aimed at addressing infectious diseases and enhancing immune responses. Its proprietary technology includes oligoDOM v1.0 and oligoDOM v2.0, which are designed to improve both B and T-cell immune responses by facilitating the uptake of antigens into dendritic cells. This results in more effective immune responses, including significant activation of CD8 T cells. Osivax's approach allows for the development of a universal vaccine targeting various infectious diseases, including influenza, malaria, and emerging coronavirus strains, while also showing potential applications in cancer treatment.
Altaroad SAS is a French company founded in 2017 that specializes in developing a SaaS-based application for real-time vehicle data capture. The company employs patented nano-sensors embedded in roadways alongside advanced algorithms to analyze and generate critical road data. This technology enables the monitoring of traffic patterns, tracking of vehicle weights, assessment of road impacts, and detection of unsafe driving behaviors. Altaroad's platform supports traffic management in smart cities by identifying maintenance needs, enhancing predictive maintenance for road operators, and facilitating cost savings for logistics providers. Additionally, the system can quickly recognize hazardous conditions, such as icy pavements, and provide feedback for autonomous vehicles, contributing to safer and more efficient road usage.
VoltAero is a manufacturer of electric aircraft that focuses on providing safe, quiet, and eco-friendly flight solutions. The company specializes in parallel electric-hybrid propulsion systems, allowing for efficient and reliable general aviation platforms. Its aircraft cater to a variety of uses, including private ownership, air taxi and charter services, and commercial flights for regional travel. By developing innovative electric aircraft, VoltAero aims to enable clients to embrace a new era of sustainable aviation.
Qarnot is a company based in Montrouge, France, founded in 2010, that specializes in providing economical and ecological high-performance computing (HPC) solutions through its innovative Q.rad computing heater. This unique product combines the functionality of an electrical heater with high-performance computing capabilities, utilizing embedded microprocessors to generate heat during computation. Qarnot's computing heaters have undergone three generations of development and are marketed to construction companies for use in new buildings. By integrating computing and heating, Qarnot offers an affordable alternative to traditional data centers, significantly reducing costs associated with infrastructure, maintenance, and cooling. Users can conveniently manage the temperature of these heaters through an embedded thermostat or a smartphone application, enhancing the overall user experience.
Xenothera SAS is a biotechnology company based in Nantes, France, focused on advancing immunological treatments through its innovative platform. Established in 2014, the company specializes in developing therapeutic solutions targeting various medical areas, including immunomodulation and infectious diseases. Its approach leverages proprietary Glyco-Humanized Antibodies and integrates expertise in animal genetics and immunology to create a new generation of hyperimmune polyclonal sera. By renovating passive immunotherapy, Xenothera aims to address unmet medical needs and facilitate the rapid development of new immunological therapies. The company's comprehensive platform allows for streamlined processes, from selecting immunogens to purifying immunoglobulins, ultimately aiming for expedited market authorization.
PKvitality is a bio-wearable company based in Paris, France, founded in 2017. The company has developed K’Track, a line of trackers that utilize its patented SKinTaste technology to analyze physiological markers through non-invasive skin testing, eliminating the need for blood samples. One of its flagship products, K’Watch Glucose, enables diabetic individuals to monitor their glucose levels continuously and conveniently, without the discomfort associated with traditional blood tests. The wearable device features a sensor that requires no calibration, provides a comprehensive data history, and sends alerts to users to remind them to check their glucose levels, enhancing the self-monitoring experience for diabetic patients.
CorWave SA is a medical device company based in Clichy, France, specializing in the development and manufacture of heart-assist pumps. Founded in 2011, CorWave focuses on innovative technologies to improve patient outcomes in advanced heart failure. Its flagship product, the CorWave Left Ventricular Assist Device (LVAD), employs a unique undulating disc wave pumping mechanism that mimics the natural pulsatile flow of the heart, significantly reducing trauma to the blood and minimizing complications such as clotting and bleeding. This technology contrasts with traditional continuous flow pumps, which lack significant pulsation. Additionally, the company offers Nemo, a minimally invasive cardiac pump designed for patients who are not candidates for LVADs, providing chronic, partial support. CorWave's devices are characterized by low power consumption and compact design, which may enable total implantability with wireless energy transfer systems.
Aledia SA develops and manufactures light-emitting diodes (LEDs). The company offers microwire LED chips based on a 3D architecture using gallium-nitride-on-silicon microwires. It provides its products for general lighting, automotive, and display applications. The company was founded in 2011 and is based in Grenoble, France with subsidiaries in Malacca, Malaysia; and Palo Alto, California.
Nestwave SAS, established in 2014 and based in Paris, France, specializes in developing geolocation systems tailored for the Internet of Things (IoT) market. The company provides innovative geolocation solutions that leverage patented hybrid-signal technology to enhance localization accuracy, particularly in challenging indoor and dense urban settings. Nestwave's platform integrates a digital signal processing (DSP) software solution, enabling IoT modem and DSP vendors to incorporate accurate geolocation capabilities into their products. This approach not only improves reliability and accuracy but also minimizes power consumption and reduces the overall footprint of the solution compared to traditional methods.
Nimesis SAS develops, manufactures, and markets memory alloys on copper and nickel-titanium in France and internationally. Its products include round or flat wires, thin ribbons, and beta 3 alloys. The company also offers smelting works, transformation, characterization, and engineering and design services to companies. Its products are used in medical, automobile, aerospace, aeronautical, clock industry, jewelery, and Microsystems industrial sectors. The company was founded in 2004 and is based in Metz, France.
Xsun designs and develops drones powered by solar energy. The company's product includes SolarXOne which is a drone model that can make its own decisions. It provides aerodynamic design which provides photovoltaic cell surface to capture the maximum amount of solar power; communication design which provides a link between the drone and the control centre; and power design. Xsun was founded in 2016 and is headquartered in Guérande, France.
Demeta S.A.S develops catalysts for green chemistry. The company offers Olefin Metathesis technology platform, which includes NexTene resins, a ruthenium catalysts; and Polymetallic Catalysis platform for oxidative cleavage of alkenes. The company was incorporated in 2011 and is based in Rennes, France.
TiHive specializes in developing advanced imaging and sensing systems that utilize miniature Terahertz technology for the inspection of textiles, plastics, and composites. The company's innovative solutions are designed to detect product defects and contaminants during in-line production processes, enabling manufacturers to monitor quality and ensure compliance. TiHive's systems are adaptable, allowing them to be integrated into various stages of production and across different machine widths. This versatility not only helps industries optimize their use of raw materials but also contributes to significant cost savings by minimizing waste and enhancing overall production efficiency.
Xsun designs and develops drones powered by solar energy. The company's product includes SolarXOne which is a drone model that can make its own decisions. It provides aerodynamic design which provides photovoltaic cell surface to capture the maximum amount of solar power; communication design which provides a link between the drone and the control centre; and power design. Xsun was founded in 2016 and is headquartered in Guérande, France.
Demeta S.A.S develops catalysts for green chemistry. The company offers Olefin Metathesis technology platform, which includes NexTene resins, a ruthenium catalysts; and Polymetallic Catalysis platform for oxidative cleavage of alkenes. The company was incorporated in 2011 and is based in Rennes, France.
omni:us is a developer of insurance claims automation software that leverages advanced artificial intelligence and natural language processing to enhance the efficiency of claims processing. The omni:us Platform allows insurers to create customized modules and swiftly integrate AI into their operations through the Cognitive Claims Kit, which addresses various use cases along the claims value chain, including document intake and coverage verification. The software is designed to work seamlessly with legacy systems, requiring no in-house AI expertise for implementation. By utilizing handwritten text recognition technology, omni:us automates data-intensive workflows and generates comprehensive claims profiles. The company aims to foster a hybrid workflow where human and machine collaboration enhances productivity. Headquartered in Berlin, omni:us has a research partnership in Barcelona and maintains a presence in the UK, France, and the United States, serving clients such as Allianz, Baloise, and AmTrust.
Antofénol is a post-harvest biocontrol company focused on reducing losses in agricultural produce, particularly in viticulture. The company specializes in the ecological eco-extraction of plant matter, utilizing innovative techniques such as microwaves, ultrasonics, vacuum, and mixing to develop tailored chemical compositions. Antofénol offers services that include eco-extraction, anti-fungal testing, and biochemical characterization, allowing harvesters to effectively protect fruits and vegetables from fungal and mold infestations. Through its approach, Antofénol aims to valorize viticultural waste while promoting sustainable agricultural practices.
Created in July 2014, Aenitis Technologies is a French start-up resulting from the work of Mauricio HOYOS and Jean-Luc AIDER, both CNRS researchers at the PMMH Laboratory (Physics and Mechanics of Heterogeneous Media at the ESPCI ParisTech, a research engineer’s school in Paris. The company focuses on medical devices’ area, where their breakthrough technologies are highly promising. Aenitis Technologies is developing innovative separation, manipulation and filtration of biological elements solutions, based on acoustophoresis technologies. The company first focuses on technological solutions that will revolutionize current practices in Public Health. Aenitis Technologies aims to become a world leader in filtering / separating solutions by acoustophoresis.